EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 19 / No 8-9 (Août-Septembre 2003) Med Sci (Paris), 19 8-9 (2003) 783-785 References
Free Access
Issue
Med Sci (Paris)
Volume 19, Number 8-9, Août-Septembre 2003
Page(s) 783 - 785
Section Le Magazine : Nouvelles
DOI https://doi.org/10.1051/medsci/20031989783
Published online 15 August 2003
  1. Bueler H, Fischer M, Lang Y, et al. Normal development and behaviour of mice lacking the neuronal cellsurface PrP protein. Nature 1992; 356: 577–82. [Google Scholar]
  2. Prusiner SB, Scott MR, De Armond SJ, Cohen FE. Prion protein biology. Cell 1998; 93: 337–48. [Google Scholar]
  3. Kovacs G, Zerbi P, Voigtlander T, et al. The prion protein in human neurodegenerative disorders. Neurosci Lett 2002; 329: 269. [Google Scholar]
  4. Ferrer I, Blanco R, CarmonaM, et al. Prion protein expression in senile plaques in Alzheimer’s disease. Acta Neuropathol (Berl) 2001; 101: 49–56. [Google Scholar]
  5. Herms J, Tings T, Gall S, et al. Evidence of presynaptic location and function of the prion protein. J Neurosci 1999; 19: 8866–75. [Google Scholar]
  6. Brown DR, Qin K, Herms JW, et al. The cellular prion protein binds copper in vivo. Nature 1997; 390: 684–7. [Google Scholar]
  7. Brown DR. Prion and prejudice: normal protein and the synapse. Trends Neurosci 2001; 24: 85–90. [Google Scholar]
  8. Mouillet-Richard S, Ermonval M, Chebassier C, et al. Signal transduction through prion protein. Science 2000; 289: 1925–8. [Google Scholar]
  9. Kuwahara C, Takeuchi AM, Nishimura T, et al. Prions prevent neuronal cell-line death. Nature 1999; 400: 225–6. [Google Scholar]
  10. Bounhar Y, Zhang Y, Goodyer CG, LeBlanc A. Prion protein protects human neurons against Bax-mediated apoptosis. J Biol Chem 2001; 276: 39145–9. [Google Scholar]
  11. Paitel E, Fahraeus R, Checler F. Cellular prion protein sensitizes neurons to apoptotic stimuli through Mdm2-regulated and P53-dependent caspase 3-like activation. J Biol Chem 2003; 278: 10061–6. [Google Scholar]
  12. Dupuis L, Mbebi C, Gonzalez de Aguilar JL, et al. Loss of prion protein in a transgenic model of amyotrophic lateral sclerosis. Mol Cell Neurosci 2002; 19: 216–24. [Google Scholar]
  13. Dupuis L, Di Scala F, Gonzalez de Aguilar JL, Rene F, De Tapia M, LoefflerJP. Denervation is not the primary cause of prion protein downregulation occuring in the spinal cord of a transgenic model of amyotrophic lateral sclerosis. Ann NY Acad Sci 2002; 973: 116–9. [Google Scholar]
  14. Zanusso G, Vattemi G, Ferrari S, et al. Increased expression of the normal cellular isoform of prion protein in inclusion-body myositis, inflammatory myopathies and denervation atrophy. Brain Pathol 2001; 11: 182–9. [Google Scholar]
  15. Lampe JB, Walter MC, Reichmann H. Neurodegenerationassociated proteins and inflammation in sporadic inclusion-body myositis. Adv Exp Med Biol 2001; 487: 219–28. [Google Scholar]
  16. Westaway D, DeArmond SJ, Cayetano-Canlas J, et al. Degeneration of skeletal muscle, peripheral nerves, and the central nervous system in transgenic mice overexpressing wild-type prion proteins. Cell 1994; 76: 117–29. [Google Scholar]
  17. Chiesa R, Pestronk A, Schmidt RE, et al. Primary myopathy and accumulation of PrPSc-like molecules in peripheral tissues of transgenic mice expressing a prion protein insertional mutation. Neurobiol Dis 2001; 8: 279–88. [Google Scholar]
  18. Miele G, Jeffrey M, TurnbullD, Manson J, Clinton, M. Ablation of cellular prion protein expression affects mitochondrial numbers and morphology. Biochem Biophys Res Commun 2002; 291: 372–7. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.